DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,397,278 | +4.1% | 41,908 | +0.7% | 0.16% | +6.7% |
Q2 2023 | $9,987,667 | -7.7% | 41,615 | -3.1% | 0.15% | -13.3% |
Q1 2023 | $10,819,769 | +11.9% | 42,929 | +17.8% | 0.17% | +4.8% |
Q4 2022 | $9,673,422 | +3.2% | 36,446 | +0.4% | 0.16% | -5.7% |
Q3 2022 | $9,374,000 | -18.6% | 36,293 | -20.1% | 0.18% | -17.1% |
Q2 2022 | $11,514,000 | -9.7% | 45,415 | +4.5% | 0.21% | +7.1% |
Q1 2022 | $12,751,000 | -6.1% | 43,470 | +5.4% | 0.20% | -4.4% |
Q4 2021 | $13,574,000 | +66.8% | 41,256 | +54.4% | 0.21% | +47.1% |
Q3 2021 | $8,137,000 | +75.7% | 26,727 | +54.9% | 0.14% | +79.5% |
Q2 2021 | $4,631,000 | -99.9% | 17,255 | -56.6% | 0.08% | -1.3% |
Q1 2021 | $8,958,788,000 | +248134.6% | 39,802 | +145.0% | 0.08% | +1.3% |
Q4 2020 | $3,609,000 | +12.3% | 16,244 | +8.8% | 0.08% | -3.7% |
Q3 2020 | $3,215,000 | +31.6% | 14,929 | +8.1% | 0.08% | +15.7% |
Q2 2020 | $2,443,000 | +26.6% | 13,814 | -0.9% | 0.07% | -1.4% |
Q1 2020 | $1,929,000 | -0.9% | 13,937 | +9.8% | 0.07% | +22.4% |
Q4 2019 | $1,947,000 | +30.9% | 12,691 | +23.2% | 0.06% | +16.0% |
Q3 2019 | $1,487,000 | +2.2% | 10,299 | +1.1% | 0.05% | -5.7% |
Q2 2019 | $1,455,000 | +8.2% | 10,185 | -0.0% | 0.05% | -7.0% |
Q1 2019 | $1,345,000 | -23.6% | 10,190 | -40.3% | 0.06% | -33.7% |
Q4 2018 | $1,760,000 | -2.9% | 17,070 | +2.4% | 0.09% | 0.0% |
Q3 2018 | $1,812,000 | +11.7% | 16,672 | +1.4% | 0.09% | -11.3% |
Q2 2018 | $1,622,000 | +93.1% | 16,436 | +91.4% | 0.10% | +67.2% |
Q1 2018 | $840,000 | +16.0% | 8,589 | +10.1% | 0.06% | +5.5% |
Q4 2017 | $724,000 | +86.1% | 7,804 | +71.7% | 0.06% | +37.5% |
Q3 2017 | $389,000 | -38.8% | 4,545 | -39.8% | 0.04% | -43.7% |
Q2 2017 | $636,000 | +2.1% | 7,545 | +3.5% | 0.07% | -24.5% |
Q1 2017 | $623,000 | – | 7,290 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |